Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
43
SYNX Quote, Financials, Valuation and Earnings
Last price:
$0.99
Seasonality move
:
38.15%
Day range:
$0.95 - $1.04
52-week range:
$0.73 - $6.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.97x
P/B ratio:
7.00x
Volume:
411.2K
Avg. volume:
157.2K
1-year change:
-71.84%
Market cap:
$5.2M
Revenue:
$9.1M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingSilynxcom Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $8.00, Silynxcom Ltd. has an estimated upside of 676.7% from its current price of $0.90.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing 100% downside risk from its current price of $0.90.
Fair Value
-
According to the consensus of 1 analyst, Silynxcom Ltd. has 676.7% upside to fair value with a price target of $8.00 per share.
SYNX vs. S&P 500
-
Over the past 5 trading days, Silynxcom Ltd. has overperformed the S&P 500 by 29.47% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Silynxcom Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Silynxcom Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Silynxcom Ltd. reported revenues of --.
Earnings Growth
-
Silynxcom Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Silynxcom Ltd. reported earnings per share of --.
Enterprise value:
8.7M
EV / Invested capital:
--
Price / LTM sales:
0.97x
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $4.3M | -- | -- | |
| Total Assets | -- | -- | $4.5M | -- | -- | |
| Current Liabilities | -- | -- | $3.1M | -- | -- | |
| Total Liabilities | -- | -- | $3.3M | -- | -- | |
| Total Equity | -- | -- | $1.3M | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-25 | 2024-12-25 | 2024-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
SYNX
Sector
Market Cap
$5.2M
$486.6M
Price % of 52-Week High
15.87%
80.87%
Dividend Yield
0%
0%
Shareholder Yield
--
1.54%
1-Year Price Total Return
-67.91%
--
Beta (5-Year)
--
0.550
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.85
200-day SMA
Sell
Level
$1.81
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.98
Relative Strength Index (RSI14)
Sell
Level
45.69
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-11.6993
50-day SMA
Sell
Level
$1.33
MACD (12, 26)
Buy
Level
0.18
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.5995)
Sell
CA Score
(Annual)
Level (-0.7816)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.0624)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Silynxcom Ltd. engages in the development, manufacture, market and sells communication headset devices. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. The company was founded on August 22, 2021 and is headquartered in Netanya, Israel.
Stock Forecast FAQ
In the current month, SYNX has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SYNX average analyst price target in the past 3 months is $8.00.
-
Where Will Silynxcom Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Silynxcom Ltd. share price will rise to $8.00 per share over the next 12 months.
-
What Do Analysts Say About Silynxcom Ltd.?
Analysts are divided on their view about Silynxcom Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Silynxcom Ltd. is a Sell and believe this share price will drop from its current level to $8.00.
-
What Is Silynxcom Ltd.'s Price Target?
The price target for Silynxcom Ltd. over the next 1-year time period is forecast to be $8.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SYNX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Silynxcom Ltd. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SYNX?
You can purchase shares of Silynxcom Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Silynxcom Ltd. shares.
-
What Is The Silynxcom Ltd. Share Price Today?
Silynxcom Ltd. was last trading at $0.99 per share. This represents the most recent stock quote for Silynxcom Ltd.. Yesterday, Silynxcom Ltd. closed at $0.90 per share.
-
How To Buy Silynxcom Ltd. Stock Online?
In order to purchase Silynxcom Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SYNX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SYNX
Sector
P/E ratio
--
19.19x
PEG ratio
-0.09x
0.18x
P/B ratio
7.00x
1.70x
Price / LTM sales
0.97x
0.85x
Growth Metrics
SYNX
Sector
Revenue growth
--
5.02%
Earnings growth
--
5.76%
Revenue (5-year growth)
--
4.27%
Earnings forecast
--
$0.39
Profitability
SYNX
Sector
Profitability FY 2024
$3.7M
$253.7M
Return on invested capital
--
4.73%
Return on assets
--
3.1%
Return on equity
--
8.11%
Earnings Date
Last Earnings Date
Sep
26
Next Earnings Date
Apr
30
Estimated Next Earnings Date
Dec
26
Balance Sheet
SYNX
Sector
Total cash
--
$139M
Short term investments
--
$32.7M
Total assets
$8.8M
$1.4B
Long term debt
--
$51.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
